Israel launches expanded Phase II trial of its COVID-19 vaccine candidate
The next five volunteers are expected to receive their first doses later this week.
President Reuven Rivlin is seen alongside the first person to receive a dose of the Israel-made coronavirus vaccine as part of the Phase II trials at Ashkelon's Barzilai Medical Center.(photo credit: AMOS BEN-GERSHOM/GPO)ByMAAYAN JAFFE-HOFFMAN
